Reported side effects are rare and generally mild: Temporary lethargy Mild swelling or irritation at the injection site Occasional digestive upset (less common with injectable forms) One area of caution: dogs with active cancer
*Terms and conditions apply
Dillman et al, 2013), and thus, there might be an ongoing requirement for KAT6A for brain function, which might also benefit from treatment increasing histone acetylation levels
After the Icelandic Medicines Agency published initial safety concerns in July 2023, regulatory bodies worldwide have launched investigations to assess the potential risk of suicidality among GLP-1 receptor agonist users
Epilepsia 1986, 27: 55-59
8-10 The ability of GLP-1 and GLP-1/GIP RAs to lower glucose as well as reduce weight led to their initial approvals for use in patients with type 2 diabetes and obesity